Your trusted resource for people with allergies, asthma, and related conditions
and for those who care for them
Allergy & Asthma Network unites and advocates on behalf of 60 million Americans with asthma, allergies, and related conditions.
Bulletin Board
September 23, 2025
AAN Expert Notes Growing Epi Nasal Spray Acceptance
Medical Advisor Payel Gupta, MD, reported to Medscape that the response from her patients over use of an epinephrine nasal spray for anaphylaxis has been “overwhelmingly positive.” Dr. Gupta also notes that teenagers appear to be more open to carrying the nasal spray because it’s small, easy to use, and does not involve needles.
AAN Advocates for Vaccine Access at CDC Hearing
Director of Advocacy Nissa Shaffi delivered testimony before the CDC’s Advisory Committee on Immunization Practices (ACIP) on the critical issue of vaccine access. Nissa emphasized how vaccines are a lifeline for people with asthma, allergies, COPD and other respiratory diseases, protecting vulnerable communities and strengthening public health.
AAN Expert Weighs In on Pediatric Asthma Study
Medical Advisor Nina C. Ramirez, MD, provided her expert perspective on a recent pediatric asthma study examining inhaled corticosteroid use and bone fractures. In an interview with Healio, Dr. Ramirez said the findings highlight the need for closer monitoring of asthma management and bone health assessments.
Allergy & Asthma in the News
Podcasts
New CSU Treatment: What Is a BTK Inhibitor Medication?
How Telehealth Works for Food Allergy Care
Omalizumab Treatment for Multiple Food Allergies: The OUtMATCH Trial
Recent & Upcoming Webinars
Check out our Events Calendar for Webinars, Trusted Messengers Events, and other Allergy & Asthma Network supported events.










